Similar articles

• Cidofovir for KS lesions.

  [No authors listed] [No authors listed] TreatmentUpdate. 2001 Oct;13(6):7. TreatmentUpdate. 2001. PMID: 11768871 No abstract available.
• Failure of cidofovir therapy in progressive multifocal leukoencephalopathy unrelated to human immunodeficiency virus.

  Houston S, Roberts N, Mashinter L. Houston S, et al. Clin Infect Dis. 2001 Jan;32(1):150-2. doi: 10.1086/317539. Epub 2000 Dec 11. Clin Infect Dis. 2001. PMID: 11112674
• Efficacy of ganciclovir and cidofovir against human cytomegalovirus replication in SCID mice implanted with human retinal tissue.

  Bidanset DJ, Rybak RJ, Hartline CB, Kern ER. Bidanset DJ, et al. Antiviral Res. 2004 Jul;63(1):61-4. doi: 10.1016/j.antiviral.2004.02.002. Antiviral Res. 2004. PMID: 15196821
• A preclinical and clinical overview of the nucleotide-based antiviral agent cidofovir (HPMPC).

  Lalezari JP, Stagg RJ, Jaffe HS, Hitchcock MJ, Drew WL. Lalezari JP, et al. Adv Exp Med Biol. 1996;394:105-15. doi: 10.1007/978-1-4757-9209-6_12. Adv Exp Med Biol. 1996. PMID: 8815677 Review. No abstract available.
• Role of cidofovir in the treatment of DNA virus infections, other than CMV infections, in immunocompromised patients.

  Snoeck R, De Clercq E. Snoeck R, et al. Curr Opin Investig Drugs. 2002 Nov;3(11):1561-6. Curr Opin Investig Drugs. 2002. PMID: 12476953 Review.